Anti-Diabetic Agents
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
PIOGLITAZONE HCL: products 1 to 20 of 30.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Accel Pioglitazone 15mg TabDIN 02303442 | Off-Formulary Interchangeable, not an ODB benefit | $1.3800per source unit | Requirements & sourcesBuild cost plan |
| Accel Pioglitazone 30mg TabDIN 02303450 | Off-Formulary Interchangeable, not an ODB benefit | $1.9600per source unit | Requirements & sourcesBuild cost plan |
| Accel Pioglitazone 45mg TabDIN 02303469 | Off-Formulary Interchangeable, not an ODB benefit | $2.9500per source unit | Requirements & sourcesBuild cost plan |
| Actos 15mg TabDIN 02242572 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Actos 30mg TabDIN 02242573 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
| Actos 45mg TabDIN 02242574 | Off-Formulary Interchangeable, not an ODB benefit | $5.2710per source unit | Requirements & sourcesBuild cost plan |
| Apo-Pioglitazone 15mg TabDIN 02302942 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Apo-Pioglitazone 30mg TabDIN 02302950 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
| Apo-Pioglitazone 45mg TabDIN 02302977 | Off-Formulary Interchangeable, not an ODB benefit | $3.3105per source unit | Requirements & sourcesBuild cost plan |
| Auro-Pioglitazone 15mg TabDIN 02384906 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Auro-Pioglitazone 30mg TabDIN 02384914 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
| Auro-Pioglitazone 45mg TabDIN 02384922 | Off-Formulary Interchangeable, not an ODB benefit | $3.3105per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Pioglitazone 15mg TabDIN 02397307 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Pioglitazone 30mg TabDIN 02365529 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Pioglitazone 45mg TabDIN 02365537 | Off-Formulary Interchangeable, not an ODB benefit | $3.3105per source unit | Requirements & sourcesBuild cost plan |
| Mint-Pioglitazone 15mg TabDIN 02326477 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Mint-Pioglitazone 30mg TabDIN 02326485 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
| Mint-Pioglitazone 45mg TabDIN 02326493 | Off-Formulary Interchangeable, not an ODB benefit | $3.3105per source unit | Requirements & sourcesBuild cost plan |
| Pioglitazone Hydrochloride Tablets 15mg TabDIN 02391600 | Off-Formulary Interchangeable, not an ODB benefit | $1.5716per source unit | Requirements & sourcesBuild cost plan |
| Pioglitazone Hydrochloride Tablets 30mg TabDIN 02339587 | Off-Formulary Interchangeable, not an ODB benefit | $2.2017per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).